Corrado Advisors, LLC Harrow Health, Inc. Transaction History

Corrado Advisors, LLC

  • $132 Million
  • Q3 2024

A detailed history of Corrado Advisors, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Corrado Advisors, LLC holds 7,366 shares of HROW stock, worth $252,064. This represents 0.25% of its overall portfolio holdings.

Number of Shares
7,366
Holding current value
$252,064
% of portfolio
0.25%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$20.85 - $46.47 $153,581 - $342,298
7,366 New
7,366 $331,000
Q4 2023

Feb 01, 2024
SELL
$8.1 - $16.36 $31,557 - $63,738
-3,896 Reduced 27.02%
10,521 $117,000
Q1 2023

May 03, 2023
SELL
$13.84 - $21.46 $26,254 - $40,709
-1,897 Reduced 11.63%
14,417 $305,000
Q4 2022

Feb 09, 2023
SELL
$10.28 - $14.78 $29,256 - $42,063
-2,846 Reduced 14.85%
16,314 $240,000
Q4 2021

Jan 14, 2022
SELL
$8.5 - $12.0 $39,100 - $55,200
-4,600 Reduced 19.36%
19,160 $166,000
Q3 2021

Oct 13, 2021
BUY
$6.99 - $10.6 $10,939 - $16,589
1,565 Added 7.05%
23,760 $216,000
Q2 2021

Jul 20, 2021
SELL
$6.68 - $11.07 $29,291 - $48,541
-4,385 Reduced 16.5%
22,195 $206,000
Q1 2021

Apr 15, 2021
SELL
$6.26 - $11.03 $31,300 - $55,150
-5,000 Reduced 15.83%
26,580 $179,000
Q4 2020

Jan 28, 2021
SELL
$4.76 - $6.93 $32,320 - $47,054
-6,790 Reduced 17.7%
31,580 $217,000
Q3 2020

Oct 07, 2020
SELL
$4.71 - $7.36 $23,691 - $37,020
-5,030 Reduced 11.59%
38,370 $214,000
Q2 2020

Jul 07, 2020
BUY
$3.61 - $6.47 $15,992 - $28,662
4,430 Added 11.37%
43,400 $226,000
Q1 2020

Apr 06, 2020
SELL
$3.5 - $7.31 $27,597 - $57,639
-7,885 Reduced 16.83%
38,970 $148,000
Q4 2019

Jan 15, 2020
SELL
$4.6 - $7.88 $4,991 - $8,549
-1,085 Reduced 2.26%
46,855 $365,000
Q3 2019

Oct 08, 2019
SELL
$4.89 - $8.0 $32,562 - $53,272
-6,659 Reduced 12.2%
47,940 $269,000
Q2 2019

Jul 10, 2019
BUY
$4.2 - $8.7 $229,315 - $475,011
54,599 New
54,599 $475,000

Others Institutions Holding HROW

# of Institutions
176
Shares Held
21.4M
Call Options Held
845K
Put Options Held
717K
View Full List

About HARROW HEALTH, INC.

HROW Quotes by TradingView
  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $926M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Corrado Advisors, LLC Portfolio

Follow Corrado Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corrado Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corrado Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email